<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Present work was carried out to study the prevalence of <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> in pediatric patients with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Detection of parvovirus B19 DNA by PCR and IgM antibodies by ELISA was carried out in 66 pediatric patients with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>45 healthy children acted as controls </plain></SENT>
<SENT sid="3" pm="."><plain>Parvovirus B19 DNA was detected in significantly higher number of patients in comparison to controls (27% vs 2%, P= 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Similarly, parvovirus B19 IgM antibodies were detected in 17 (25.8%) patients as against one control (2.2%) which again was statistically significant </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical and hematological profile of the patients with or without <z:e sem="disease" ids="C0205882" disease_type="Disease or Syndrome" abbrv="">parvovirus infection</z:e> was comparable </plain></SENT>
</text></document>